Therapeutic use of the high-density lipoprotein protein and peptides

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.3, 2006-03, pp. : 227-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic agents that raise high-density lipoprotein cholesterol levels

By Rodriguez Annabelle Doshi Rajiv R

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 167-175

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1480-1493

Bentham Science Publishers

Access to resources Recommend Favorite

Raising high-density lipoprotein cholesterol with inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1365-1368

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite

High-Density Lipoprotein-Raising Strategies: Update 2010

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1517-1530

Bentham Science Publishers

Access to resources Recommend Favorite